Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Elicio Therapeutics, Inc.”

4 pharma patents match "Elicio Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Elicio Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Elicio Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12370245

    ALK polypeptides and methods of use thereof

    Elicio Therapeutics, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12247052

    CpG amphiphiles and uses thereof

    Elicio Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted

  3. US 12138301

    Compounds including a mutant KRAS sequence and a lipid and uses thereof

    Elicio Therapeutics, Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted

  4. US 11623002

    ALK polypeptides and methods of use thereof

    Elicio Therapeutics, Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.